Thought Leadership

Since 1995, PwC has periodically surveyed the life sciences industry on its working relationship with its chief regulatory agency, the US Food and Drug Administration (FDA). This series comprising five surveys is meant to provide insight to FDA and the industry on how to expand trust and build on their relationship. The most recent survey, concluded in summer 2010, was undertaken jointly by PwC's Pharmaceuticals and Life Sciences R&D Advisory Services team and BIOCOM, the world's largest regional life sciences association, representing 550 Southern California life sciences companies.

•